SageTech Medical Company Profile

Background

Founded in 2015 in Paignton, Devon, UK, SageTech Medical is a medical device and pharmaceutical company dedicated to mitigating the environmental impact of healthcare practices. The company's mission is to capture and recycle waste volatile anaesthetic agents, thereby reducing their harmful release into the atmosphere. SageTech Medical has developed proprietary technologies that integrate seamlessly into existing anaesthetic equipment, offering a sustainable solution to a significant environmental challenge.

Key Strategic Focus

SageTech Medical's strategic focus centers on the development and deployment of its innovative anaesthetic gas capture and recycling system. This system is designed to safely capture waste volatile anaesthetic agents such as sevoflurane, isoflurane, and desflurane, which are then recovered and purified for future reuse. By implementing this circular economy solution, the company aims to assist healthcare providers in reducing their carbon footprint and promoting environmental sustainability.

Financials and Funding

Over the years, SageTech Medical has secured multiple funding rounds to support its growth and technological advancements. In November 2024, the company received £650,000 in funding led by EMV Capital plc, with participation from Animal Health Angels. Additionally, in May 2023, SageTech Medical launched a crowdfunding campaign on Crowdcube, aiming to raise £600,000 to support its expansion in the UK and Europe.

Technological Platform and Innovation

SageTech Medical's flagship product is the SID-Dock, a UK Conformity Assessed (UKCA) marked, Class I medical device designed for the safe and sustainable capture of volatile anaesthetic gases. The SID-Dock integrates seamlessly with existing anaesthetic equipment, allowing for the efficient collection of waste gases without disrupting clinical workflows. Captured gases are then transported to regional hubs, where they are recovered and purified to yield greener active pharmaceutical ingredients.

Leadership Team

Dr. Iain Menneer, CEO: Joined in November 2019, bringing extensive experience in the pharmaceutical industry, including a tenure as CEO of Animalcare Group plc.

Dr. Steve Wileman, Head of Research: Joined in January 2016, overseeing the company's research and development programs.

Darren Barrett, Head of Engineering: Joined in November 2020, responsible for the design and development of engineering solutions.

Luke Rawlinson, Head of Commercial: Joined in June 2021, leading the commercialization efforts of the company's products.

Dr. Matt Gopal, Head of Stakeholder Engagement: Joined in July 2017, managing relationships with key stakeholders.

Liam Mulholland, Head of Business Development: Joined in October 2021, focusing on business development strategies.

Su Finlay, Regulatory Compliance Lead: Joined in December 2020, ensuring compliance with relevant laws and regulations.

Leadership Changes

In November 2019, Dr. Iain Menneer was appointed as CEO, bringing with him a wealth of experience from the pharmaceutical sector.

Competitor Profile

Market Insights and Dynamics

The healthcare industry is increasingly focusing on sustainability, with a particular emphasis on reducing the environmental impact of medical practices. Anaesthetic gases are significant contributors to greenhouse gas emissions, prompting the need for innovative solutions to mitigate their release. SageTech Medical's technology addresses this need by offering a system that captures and recycles these gases, aligning with global sustainability goals.

Competitor Analysis

While specific competitors are not detailed in the available information, companies operating in the medical device sector with a focus on environmental sustainability may be considered competitors. SageTech Medical's unique approach to capturing and recycling anaesthetic gases positions it distinctively in the market.

Strategic Collaborations and Partnerships

SageTech Medical has established several strategic partnerships to expand its market reach:

Dräger UK: In 2024, SageTech Medical signed a distribution agreement with Dräger UK, facilitating access to the NHS supply chain and enhancing the availability of the SID-Dock device to NHS customers.

Dräger Switzerland: In February 2025, the company entered into a distribution agreement with Dräger Schweiz AG to introduce its anaesthetic gas capture technology to the Swiss market.

Matclinic: In 2025, SageTech Medical partnered with Matclinic to bring its innovative technology to Spain.

Operational Insights

SageTech Medical's technology is designed to integrate seamlessly with existing anaesthetic equipment, ensuring ease of adoption for healthcare providers. The company's focus on environmental sustainability, combined with its innovative approach to capturing and recycling anaesthetic gases, provides a competitive advantage in the market. Strategic partnerships with established medical device distributors further strengthen its market position.

Strategic Opportunities and Future Directions

Looking ahead, SageTech Medical aims to expand its presence in international markets through strategic partnerships and distribution agreements. The company is also focused on continuous innovation to enhance the efficiency and effectiveness of its gas capture and recycling technology. By aligning with global sustainability initiatives, SageTech Medical is well-positioned to play a pivotal role in reducing the environmental impact of anaesthetic gases in healthcare.